Image Description

Mohamad Mehanna


Pharmaceutical Technology Department


mmhanna@bau.edu.lb


01 300110 Ex: 2867


Beirut


Mohamad Mehanna

Assistant Professor of Pharmaceutical Technology


Mohammed M. Mehanna studied pharmaceutical sciences at the Faculty of Pharmacy, Alexandria University. Mohammed received his B.Sc. and M.Sc. degree (with the highest honours) in Pharmaceutical Sciences from Alexandria University in 2001 and 2008, respectively. In 2010, Mohammed received his Doctor of Philosophy in Pharmaceutical sciences from the same university . Mohammed spent the academic year 2013/2014 as Visiting Assistant Professor at the University of Mutah, Hashemite Kingdom of Jordan. In 2012, Mohammed joined Department of Pharmaceutical Technology, Faculty of Pharmacy at Beirut Arab University as an Assistant Professor. In 2016, Mohammed was promoted to Associate Professor. His research interests cover the field of nanopharmacuticals and modern drug delivery systems such as lipid and polymer-based nanostructures for a wide variety of pharmaceutical applications. He has published several research articles in the field of nanocarriers as vehicle for drug delivery.

Download CV as PDF

Teaching

Research

Research interest

My research interest currently focuses on two main areas: at the macro-pharmaceutical level, I’m interesting in developing non-invasive drug delivery systems with a particular emphasis on tailoring carriers through different routes of administration. Fundamental pharmaceutical concepts in drug solubilization and controlled-release drug delivery are of interest. In addition to, the elaboration and appraisal procedures and techniques of micro-sized pharmaceutical carriers. Mathematical optimization and assessment of delivery systems covers various routes of administration viz. oral, transdermal, pulmonary and ocular is considered an area of my speciality. At the nanotechnology level, my core of research is the application of nanotechnology in the field of drug delivery with special interest in anticancer and anti-bacterial drugs and targeting. More precisely, these investigations of polymer-, lipid- and peptide-based nano-carriers allow us to explore their in vivo performance on molecular and animal models.

Recent publications

1. Mohammed M. Mehanna, Souraya Domiati, Hanan Ragab, Hania Nakkash Chmaisse, Ahmed El Mallah. “Antinociceptive Effect of Tadalafil in Various Pain Models: Involvement of Opioid Receptors and Nitric Oxide cyclic GMP Pathways” Journal of Toxicology and Applied Pharmacology, 2018; 352: 170-175

2. Souraya Domiati, Mohammed M. Mehanna, Hanan Ragab, Hania Nakkash Chmaisse, Ahmed El Mallah. “Investigation of chronic efficacy and safety profile of two potential anti-inflammatory bipyrazole-based compounds in experimental animals” Journal of Inflammation Research, 2018; 11:143-153

3. Mohammed M. Mehanna, Nourane Abdelkader, Magda W. Samaha. “Liposomes as a potential carrier for ketorolac ophthalmic delivery: formulation and stability issues” Brazilian Journal of Pharmaceutical Sciences, 2017; 53(2):e16127

4. Mohammed M. Mehanna. “Design and physicochemical characterization of isinopril–loaded nanocapsules for paediatric use", International Journal of Pharmacy and Technology, 2016; 9(1): 28149-28162

5. Salma M. Mohyeldin, Mohammed M. Mehanna, Nazik A. Elgindy. “Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence”. Expert Opinion on Drug Delivery, 2016;13(8): 1049-1064

6. Salma M. Mohyeldin, Mohammed M. Mehanna, Nazik A. Elgindy. “The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity”. International Journal of Nanomedicine, 2016;11: 2209—2222

7. Nazik A. Elgindy, Mohammed M. Mehanna, Salma M. Mohyeldin. “Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery”. International Journal of Pharmaceutics, 2016; 501: 167–179

8. Ahmed Allam, Mohammed M. Mehanna. Formulation, physicochemical characterization and in-vivo evaluation of ion-sensitive metformin loaded-biopolymeric beads. Drug Development and Industrial Pharmacy. 2016; 42(3): 497–505

Activities

Scientific activities:

  • Consulting editor at International Journal of Nanomedicine
  • Editorial board Member of

a. Journal of Novel Drug Delivery Technology

b. Insights in Tuberculosis

c. Journal of Bioavailability and Bioequivalence

d. International Journal of Pharmacy and Biotechnology

  • Peer reviewer in many highly ranked international journals in pharmaceutics and pharmaceutical technology, among them:

International Journal of Pharmaceutics.

International Journal of Nanomedicine.

Journal of Pharmaceutical Science.

Journal of Molecular Pharmaceutics.

Drug Design, Development and Therapy

Drug Development and Industrial Pharmacy.

Drug Delivery

Journal AOAC International

Pharmaceutical Research

Other activities:

  • Member of scientific research committee, Beirut Arab University, Lebanon.
  • Head of library committee, Faculty of Pharmacy, Beirut Arab University, Lebanon.
  • Member of postgraduate studies and scientific research committee, Faculty of Pharmacy, Beirut Arab University, Lebanon.
  • Member of strategic planning committee, Faculty of Pharmacy, Beirut Arab University, Lebanon.
  • Academic advisor for undergraduate students from different levels, Faculty of Pharmacy, Beirut Arab University, Lebanon.
  • Member of the Faculty Quality Assurance Unit, Faculty of Pharmacy, Beirut Arab University, responsible for preparation of Canadian pharmacy program accreditation (CPPA) visit, 2014.

Awards

  1. The best Ph.D. thesis in basic and multidisciplinary sciences from Alexandria University
  2. Reward of Alexandria University for publication in top 5% of pharmacy and pharmacology journal rank (several times)
  3. Faculty of Medicine, Alexandria University Appreciation Plaque for Safe Water in Health Institutes seminar.